Healthcare

Lumos Diagnostics Holdings Ltd (ASX:LDX) is a medical diagnostics company focused on developing rapid point-of-care testing solutions. Its lead product, FebriDx, is designed to help clinicians assess whether an acute respiratory infection is more likely bacterial or viral. This article examines how regulatory progress …

Syntara Limited (ASX:SNT) is a clinical-stage biotechnology company developing medicines for serious diseases. The company's lead programme is amsulostat, a pan-lysyl oxidase inhibitor being studied in myelofibrosis, a condition involving scarring of the bone marrow. This article examines the company's clinical progress, regulatory pathway …

Noxopharm Limited (ASX:NOX) is an Australian clinical-stage biotechnology company developing therapies based on immune system modulation. The company’s Sofra platform uses synthetic oligonucleotides designed to influence innate immune responses, while its Chroma platform focuses on oncology applications. This article examines Noxopharm’s technology platforms and …

Epsilon Healthcare Limited (ASX:EPN) is an Australian healthcare company focused on pharmaceutical manufacturing, clinical services and medicinal cannabis-related activities. Through its manufacturing subsidiary, Epsilon Pharma, the company is seeking to utilise its pharmaceutical-grade production capabilities to support third-party brands and expand into international markets. …

Cambium Bio Limited (ASX:CMB) is a Sydney-based regenerative medicine company developing biological therapies. The company is advancing Elate Ocular, an investigational treatment for dry eye disease, with its current focus centred on progressing through clinical development and regulatory requirements.

Paradigm Biopharmaceuticals Ltd (ASX:PAR) is a biotechnology company developing therapies based on pentosan polysulfate sodium. The company’s current focus is advancing Zilosul through clinical development for osteoarthritis, with its Phase 3 trial representing a major stage in the programme.

Rhythm Biosciences Limited (ASX:RHY) is an Australian medical diagnostics company developing technologies aimed at improving cancer detection. The company’s lead product, ColoSTAT, is being developed as a blood-based assessment tool for colorectal cancer risk, with commercialisation and regulatory progress forming key parts of its …